National Actions | BEAM Alliance

National Actions

Beyond its work at the EU level, the BEAM Alliance also interacts with national stakeholders, both within and outside the EU. The aim is to encourage EU Member States to actively contribute to exchanges on AMR in the co-legislative process and for every state to put in place their own plan to combat AMR, in particular by supporting innovation.

To achieve this, BEAM relies on a network of National Coordinators among its members, whose role is to carry the voice of SMEs by adapting it to the national context. These different National Coordinators are listed below.

BEAM National Coordinators

 

AUSTRIA
BioNTech R&D: Alexander Belcredi

BELGIUM
Santero Tx: Cédric Govaerts

DENMARK
Disperazol: Michael Graz

FINLAND
Arivin:Chris Jonkergouw

FRANCE
AUROBAC Tx: Florence Séjourné
ANTABIO: Marc Lemonnier

GERMANY
AiCuris: Holger Zimmermann
HYpharm: Ingrid Wanninger

ICELAND
Akthelia: Egill Masson

IRELAND
Assuré Medical: Ger Okeeffe

 

ISRAEL
Omnix Medical: Niv Bachnoff

ITALY
F2G: Daniela Zinzi

PORTUGAL
Immunethep: Bruno Santos

SPAIN
ABAC Tx: Domingo Gargallo-Viola

SWEDEN
QureTech Bio: Helén Fält

SWITZERLAND
Debiopharm: Morgane Vanbiervliet
BioVersys:  Marc Gitzinger

NETHERLANDS
SurvivX: Remko Van Leeuwen

UK
Infex Tx: Pete Jackson